NASHVILLE, Tenn., July 15, 2025 (GLOBE NEWSWIRE) -- Tivity Health, a leading provider of healthy lifestyle solutions, including SilverSneakers®, Prime® Fitness, and WholeHealth Living®, announced today that Natasha Deckmann, M.D., has been named Chief Executive Officer. Ms. Deckmann is an experienced strategic healthcare operator with over 20 years of leadership across healthcare services, health systems, financial services and consulting. She joined Tivity Health in 2024 as Chief Transformation Officer an ...

SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene as well as certain of Centene’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene cl ...

Astrana Health, Inc. (ASTH) closed the last trading session at $25.12, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $49.56 indicates a 97.3% upside potential.The average comprises nine short-term price targets ranging from a low of $36.00 to a high of $70.00, with a standard deviation of $12.39. While the lowest estimate indicates an increase of 43.3% from the curre ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are ...

SAN FRANCISCO, July 15, 2025 /PRNewswire/ -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange A ...

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchan ...

China Healthcare Service & Devices 2Q25 preview: new order momentum key for CDMO; eyes on recovery for in-hospital surgeries and consumption As we head into the 2Q25 earnings season, we've seen a pickup in investor inquiries around CRO/CDMO, Medtech, and Services and exploring potential trading opportunities, following strong performance in biotech/pharma. While Biotech remain our top-ranking sub-sector within our coverage (see Ziyi's report), we believe 2Q earnings releases in the CDMO segment could cataly ...

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene class act ...

Core Viewpoint - Kaskela Law LLC is investigating National HealthCare Corporation (NHC) due to a significant decline in its stock price, which has dropped nearly 20% since November 2024 [1][2]. Group 1: Stock Performance - NHC's common stock has decreased from over $135.00 per share to below $110.00 per share, representing a decline of nearly 20% in value [1]. Group 2: Legal Investigation - The investigation aims to determine if NHC and its officers and directors violated securities laws or breached fiduciary duties related to recent corporate actions [2]. - Shareholders of NHC are encouraged to contact Kaskela Law LLC for more information regarding their legal rights and options [2].

Core Viewpoint - The Centene class action lawsuit alleges that Centene Corporation and its executives misled investors regarding the company's revenue outlook and growth potential during the specified class period, leading to significant financial losses for shareholders [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Lunstrum v. Centene Corporation and covers the period from December 12, 2024, to June 30, 2025 [1]. - The lawsuit claims that Centene provided false information about its projected revenue and growth, particularly regarding enrollment rates and morbidity [3]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, resulting in a significant stock price drop of over 40% [4]. Group 2: Financial Impact - The preliminary analysis indicated that over two-thirds of Centene's marketplace share showed lower-than-anticipated enrollment and increased morbidity, contradicting the company's optimistic reports [3]. - Following the withdrawal of guidance, Centene's adjusted diluted EPS was reduced to approximately $2.75, with a total guidance reduction to about $1.8 billion [4]. Group 3: Legal Process - Investors who suffered losses during the class period can seek to become the lead plaintiff in the lawsuit, representing the interests of all class members [5]. - The lead plaintiff has the authority to select a law firm for litigation and does not need to be the lead plaintiff to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for securing significant monetary relief for investors and has a strong track record in handling large securities class action recoveries [6].